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Abstract
Background: In the face of the dual TB/HIV epidemic, the ProTEST Initiative was one of the first
to demonstrate the feasibility of providing collaborative TB/HIV care for people living with HIV
(PLWH) in poor settings. The ProTEST Initiative facilitated collaboration between service
providers. Voluntary counselling and testing (VCT) acted as the entry point for services including
TB screening and preventive therapy, clinical treatment for HIV-related disease, and home-based
care (HBC), and a hospice. This paper estimates the costs of the ProTEST Initiative in two sites in
urban Zambia, prior to the introduction of anti-retroviral therapy.
Methods: Annual financial and economic providers costs and output measures were collected in
2000–2001. Estimates are made of total costs for each component and average costs per: person
reached by ProTEST; VCT pre-test counselled, tested and completed; isoniazid preventive therapy
started and completed; clinic visit; HBC patient; and hospice admission and bednight.
Results: Annual core ProTEST costs were (in 2007 US dollars) $84,213 in Chawama and $31,053
in Matero. The cost of coordination was 4%–5% of total site costs ($1–$6 per person reached).
The largest cost component in Chawama was voluntary counselling and testing (56%) and the clinic
in Matero (50%), where VCT clients had higher HIV-prevalences and more advanced HIV. Average
costs were lower for all components in the larger site. The cost per HBC patient was $149, and
per hospice bednight was $24.
Conclusion: This study shows that coordinating an integrated and comprehensive package of
services for PLWH is relatively inexpensive. The lessons learnt in this study are still applicable today
in the era of ART, as these services must still be provided as part of the continuum of care for
people living with HIV.
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Background
Recently there have been major improvements in access to
treatment for people living with HIV (PLWH) in develop-
ing countries [1]. Provision of anti-retroviral therapy
(ART) has moved to the top of the international health
policy agenda and scaling-up is in rapid progress. How-
ever, ART is only one of many services critical to PLWH
throughout their lives. It is widely acknowledged that to
make a dent in the HIV epidemic in Africa an integrated
approach is needed, addressing prevention, treatment and
care [1-4]. The Zambian ProTEST Initiative was a pilot
study of an integrated model for providing a comprehen-
sive package of services for PLWH at all stages of infection.
This package was developed prior to the availability of
ART, but remain important in the current service package
for the continuum of care. Services within this package
include voluntary counselling and HIV testing (VCT) with
outreach by youth friendly services, active TB case-finding,
TB preventive therapy, an HIV-clinic, HBC, and a hospice,
each within a coordinated network of service providers
and referral systems.
The appropriateness of these individual ProTEST compo-
nents has previously been established. Co-ordination of
services is expected to improve access to prevention and
care [5,6]. VCT has been shown to induce short-term
reported behaviour change, that should reduce the inci-
dence of HIV [7-10]. VCT also provides a valuable oppor-
tunity for active TB case finding, for referral to and/or
provision of TB treatment and prevention, and for referral
to other services for PLWH [11]. Isoniazid preventive ther-
apy (IPT) reduces the incidence of TB in PLWH [12-16].
Both screening, treatment and IPT may lead to the preven-
tion of secondary TB cases, by shortening and preventing
the infectious period of TB in HIV co-infected people [5].
HBC can alleviate the pressure on hospital in-patient serv-
ices, lighten the load on family caregivers, improve quality
of life for AIDS patients and reduce stigma related to HIV/
AIDS [17-22] in [23,24]. It is likely that this would also
hold for palliative care and hospice care. Moreover, palli-
ative care that treats the side effects of ART will improve
adherence to ART [25-27]. Providing a range of services
for PLWH, such as IPT, ProTEST clinic, hospice and HBC,
is also likely to serve as an incentive to present earlier for
HIV testing [5].
Although some evidence exists on the costs of these indi-
vidual services (VCT, IPT, HBC) [28-37], there is little data
on the costs of providing services jointly and no costs of
hospice care in Africa have been published. This study
examines the costs of both starting-up and implementing
a package of HIV services in Lusaka, Zambia. These pro-
vide baseline cost estimates that have been identified as
lacking in many estimates of global resources needed for
providing a full continuum of care for PLWH [38].
Methods
Study sites
The Zambian ProTEST pilot project began in 1999 as a
collaboration including the Zambian AIDS-related TB
project (ZAMBART), Kara Counselling and Training Trust
(KCTT), local primary health clinics, youth friendly serv-
ices (YFS), district health authorities, and the Archdiocese
of Lusaka. Together they provided: VCT with IPT for TB
prevention, community outreach, a clinic for manage-
ment of HIV-related illness, hospice, and HBC. Although
these services operated independently, through collabora-
tion and improved referral systems they formed an inte-
grated package. The initial impetus for the intervention
was the dual HIV/TB epidemic being seen in Lusaka with
its high HIV prevalence (22%) [39] and high incidences of
TB (653/100,000 per annum) in Zambia in 2001 [40].
Public sector ART was introduced as a pilot in 2002, and
was rapidly rolled out and scaled up [41]. By March 2007,
98,500 people were receiving ART in Zambia [42]. This is
about half of the estimated 200,000 people in need of
ART [42]. Improved referral systems need to be in place to
support this rapid scale up of ART underway in Zambia.
ProTEST Zambia was implemented in two high-density
low income urban compounds in Lusaka: Chawama and
Matero. Prior to ProTEST, the Chawama health clinic
already had a VCT centre providing IPT as part of a study.
The ProTEST Initiative in Chawama built a new building
for this growing service, introduced monthly co-ordina-
tion meetings and strengthened the referral system, sup-
ported YFS to provide outreach, and established the
ProTEST clinic. The costing took place in the second year
of ProTEST operation. Matero was a completely new site,
opening in November 2000. ProTEST established a VCT
and other ProTEST services, and included chest x-rays as
part of their process for TB screening. The two sites dif-
fered slightly in their spatial integration: Chawama's VCT
and clinic were in stand-alone buildings within the PHC
grounds, while in Matero they were situated within the
main hospital building.
Intervention components
The core components of ProTEST were considered to be
co-ordination, VCT, IPT, ProTEST clinic, and outreach.
Hospice and HBC were considered affiliated services. The
heart of the ProTEST Initiative was coordination of the dif-
ferent services. This was done by the ProTEST team at
ZAMBART. The team consisted of a medical doctor/man-
ager, a clinical officer, an outreach worker/drama coordi-
nator, a driver, and had input from a secretary (50%) and
an expatriate director (20%). The team also participated
directly in many of the services provided. They set up and
monitored the IPT, ran the weekly ProTEST clinics, and
organised the outreach programme. The clinicians pro-
vided weekly medical services to the hospice.Cost Effectiveness and Resource Allocation 2008, 6:2 http://www.resource-allocation.com/content/6/1/2
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Coordination
The aim of the coordination component was to
strengthen collaboration and channels of communication
between traditionally vertical TB and HIV services that
were serving much of the same population. The main tan-
gible activity was meetings among the different service
providers to coordinate their services and strengthen their
mutual referral systems (Figure 1). Lunch and transporta-
tion were provided to participants. Service providers
attending meetings included representatives from all core
and affiliated services and other groups working on HIV
or TB such as support groups for PLWH, government
department of health employees, and other community
organisations.
In Chawama, meetings ranged from 12 to 40 participants,
averaging 33 participants, and in Matero they ranged from
15 to 25 participants, averaging 19 participants. Although
the meetings were planned as monthly events, during the
period of the costing, there were 6 meetings in Chawama.
In Matero there were 5 meetings during the 3-month start-
up period and 3 in the year of the costing.
VCT and IPT
VCT served as the entry point for the ProTEST Initiative.
Services were provided by nurses with counselling train-
ing. During pre-test counselling clients were syndromi-
cally screened for STIs, and if need be referred for
treatment. Rapid HIV tests were used, making it possible
to provide test results to clients on the same day. During
post-test counselling HIV-infected people were screened
for active TB. People with suspected active TB were
referred to the ProTEST clinic for further evaluation of TB
and if confirmed they were sent to the national TB serv-
ices. All other HIV-positive clients with no TB symptoms
were offered IPT. IPT consisted of a six-month self-admin-
istered course of isoniazid (300 mg daily), collected
monthly by clients from the VCT counsellors. Addition-
ally, VCT clients were provided information on services
for PLWH.
The Chawama VCT centre was located in a stand alone
building in the hospital compound. It had a large recep-
tion with smaller counselling rooms around the edge.
During the year of the costing counsellors increased from
three to six. In addition to the outreach activities
described below, the Chawama VCT centre used commu-
nity mobilisers to draw people in for VCT, who were pro-
vided a bonus for each person presenting for pre-test
counselling. In Matero, the VCT was a room within the
main hospital building. There was a single counsellor. The
waiting room was a bench in the hospital corridor.
Outreach
Outreach was provided through YFS. With support of the
ZAMBART drama coordinator, YFS volunteers wrote and
performed dramas in the communities and recorded them
on video to provide information on HIV prevention, the
ProTEST Initiative, and the benefits of VCT. Each group
received a nominal allowance. A 4-month outreach
project targeted at sex-workers and their clients was imple-
mented by the Chawama YFS. YFS in Chawama was allo-
cated two rooms in the new VCT building. In Matero the
health clinic provided them with a room.
ProTEST clinic
The ProTEST clinics served HIV-infected individuals who
had passed through VCT. These weekly clinics specialised
in treating opportunistic infections and other HIV-related
diseases and they were staffed by the ZAMBART doctor
and medical officer. The clinicians also referred clients to
community services such as hospice and HBC. Drugs were
provided free of charge to patients. Treatment did not
include the provision of ART during the time of this study,
although ProTEST clients have more recently been able to
access ART. The ProTEST clinic was held in 2 rooms of the
newly built ProTEST building in Chawama, and in a con-
sulting room in the hospital in Matero.
HBC
The Archdiocese of Lusaka ran a community HBC pro-
gramme throughout Zambia, including Chawama and
Matero. Volunteer caregivers provided care and delivered
food supplements to ill patients in their homes. With their
strong links in the communities, they were in a position
to refer people for VCT and into the ProTEST system.
Hospice
In addition to VCT, KCTT also ran a hospice which served
terminally ill patients referred in from Chawama, Matero,
and other compounds. The hospice had a total of 20 beds
for adults. In addition to core staff, ZAMBART provided
the services of a medical doctor and a medical officer to
ProTEST Zambia and its referral systems Figure 1
ProTEST Zambia and its referral systems. Arrows 
depict the direction of referrals; VCT: Voluntary counselling 
and testing; YFS: Youth friendly services; PLWH: People liv-
ing with HIV; STI: sexually transmitted infection.
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the hospice on a weekly basis. Community organisations
provided about a third of the caregiver time.
Costs
Cost data collection was based on the Costing Guidelines
for HIV Prevention Strategies [43]. In both sites annual costs
and intermediate outcome indicators were collected
between November 2000 and October 2001, with the
exception of HBC where the period was January to
December 2000.
Full costs were collected for all ProTEST components,
except IPT, where incremental costs of adding IPT on to
routine VCT services were estimated. Full costs include the
value of space, vehicles, and all operating expenses. In
Matero, this also includes a depreciated value of start-up
costs.
All costs were adjusted to 2007 US dollars ($), including
costs quoted from other studies, using a GDP deflator
[44], the 2006 GDP deflator (3.2%) was also applied to
2007 as this was not yet available. The average exchange
rate during the main costing period was used (3,622
Kwacha per US Dollar ($)) [45].
Financial and economic costs were estimated from a pro-
vider's perspective. Financial costs represent actual
expenditure on goods and services purchased. These were
based on financial accounts and financial reports. Eco-
nomic costs include the estimated value of all resources
used in the intervention, such as the opportunity cost of
service providers attending coordination meetings, YFS
and HBC volunteers, and donated goods such as HIV test
kits and space. An inventory of donated time and volun-
teer staff input was made either from logs of donations or
interviews during site visits. Unit costs were assessed for
volunteer time by either the salary of the individual
donating time or minimum wage, for unemployed indi-
viduals. The value of donated goods were assessed from
market prices (for food donations), pharmacies (for med-
icines and medical supplies) and from the internet (for
HIV test kits not available in country). The annual finan-
cial cost of capital goods was calculated using straight-line
depreciation, in which the total cost of the good was
divided by the length of its working life. The annual eco-
nomic cost of capital goods was calculated using a 3% dis-
count rate, as recommended by Weinstein et al. [46].
Cost data were collected from administrative records from
the service providers (KCTT, ZAMBART, and the Archdio-
cese of Lusaka), observation at study sites, and discussions
with project staff. As ProTEST started in the Chawama site
prior to the costing, it was not possible to collect full start-
up costs there. Start-up costs related to integrating services
in Matero were collected, and are presented separately.
Costs were collected retrospectively using a combination
of an ingredients-based costing methodology, whereby
quantities of resources were multiplied by their respective
prices to obtain total costs, and a step-down methodol-
ogy, where joint costs were allocated to activities using
allocation factors [47]. Each service was costed independ-
ently, with an allocation of indirect cost for those services
provided by the same provider, specifically ProTEST coor-
dination, IPT, Outreach, and ProTEST clinic, which were
provided by the ZAMBART project team and the VCT cen-
tres which were provided by KCTT. Costs from the ZAM-
BART project office, that could not be directly allocated to
components, including capital costs, were allocated across
core services (except VCT, which was provided by KCTT)
using direct financial component costs as allocation factor
and placed in the category 'Indirect costs'. To allocate
KCTT central/administrative costs to the VCT centres and
hospice, costs were first allocated to VCT and 'Other serv-
ices' according to direct costs, then allocated to Chawama
and Matero according to the respective sites' proportion of
total people tested for HIV. The 'indirect costs' category
included depreciation of capital goods, including vehicles
which could not be separated out precisely. The hospice
was allocated a portion of 'Other' KCTT administration
costs according to its share of direct costs in 'Other' direct
costs. Because HBC did not record site specific costs, pro-
gramme costs were allocated proportionately to Cha-
wama and Matero by their share of total patients.
Outcomes and average costs
Component total costs were divided by the component
outcomes to obtain component average costs (unit costs).
As the first point of contact with the ProTEST Initiative
was through the VCT service, the number of people pre-
test counselled was taken as the number of people reached
by ProTEST. The impact of VCT was measured using the
number of people: pre-test counselled, tested, tested HIV-
positive, and completing the VCT process (receiving their
results). IPT compliance is known to be a problem [48],
therefore both the numbers of people starting and com-
pleting IPT were used. People were considered to have
completed IPT if they finished the 6-month course within
eight months. The indicator used for HBC was the annual
number of patients, estimated as the average of the
number of patients at the start and at the end of the year.
Cost per visit would have been desirable, but was not
available. For hospice it was possible to calculate both the
cost per admission and the cost per bednight.
Sensitivity analysis
A univariate sensitivity analysis was performed to under-
stand how assumptions made in this analysis affected the
unit costs of ProTEST. We varied the discount rate (0%
and 6%), we estimated the impact of full VCT compliance,
a twice as rapid loss to follow-up for IPT, and variance inCost Effectiveness and Resource Allocation 2008, 6:2 http://www.resource-allocation.com/content/6/1/2
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the number of ProTEST clinic visits (up and down by
25%), the allocation factor of ZAMBART joint costs (equal
amounts across components, rather than proportionate to
direct costs). In addition, the impact of having a interna-
tional director was tested by replacing the international
salary with a local salary, taken as that of the local project
coordinator.
Results
ProTEST total costs
Component costs are presented by input in Tables 1, 2, 3,
and their contribution to total annual costs in Figure 2.
The total annual economic cost of ProTEST core compo-
nents was $84,213 in Chawama and $32,347 in Matero.
The annual economic cost of ProTEST co-ordination was
$1,446 in Matero and $4,225 in Chawama, 4%–5% of site
costs in both. Matero start-up costs were treated as capital
and were annualised using a 3% discount rate, this came
to a cost of $899 per year, which would increase ProTEST
co-ordination costs to 8% of site costs.
Total annual economic costs of VCT were $47,598 in Cha-
wama and $8,532 in Matero, of which 27% and 39% were
for supplies. Financial costs for supplies were 30% and
18% of their economic costs, in Chawama and Matero,
respectively, primarily due to large donations of HIV test
kits. The total annual incremental cost of adding IPT on to
VCT was $1,373 in Chawama and $1,300 in Matero,
where x-rays were a routine part of the screening process.
Outreach by YFS was $9,884 and $5,078 in Chawama and
Matero per year, respectively. In Chawama, the higher
outreach costs were largely due to a 4-month outreach
intervention targeted at sex-workers and their clients.
Much of the outreach by YFS was run by volunteers, lead-
ing to the economic costs being more than twice the
financial costs in the new site. The annual cost of the clinic
was $21,132 and $15,991 in Chawama and Matero,
respectively, which contributed to 25% and 49% of total
costs in each, respectively.
There was a large difference between the financial and
economic costs in the affiliated services, HBC and hos-
pice, with their economic costs being 4.4 and 2.6 times
their financial costs. HBC paid for only 39% of labour and
13% of supplies as their care-givers were primarily volun-
teers and they received large food donations from interna-
tional organisations such as the World Food Programme.
The hospice received 85% of their supplies in donations
of which 57% was medicines supplied by the Archdiocese
of Lusaka and 43% was other supplies coming from com-
munity donations. A further breakdown of personnel and
supply inputs and their contribution to personnel and
supplies, respectively, can be found in Table 4. No break-
Contribution of core components to site total costs Figure 2
Contribution of core components to site total costs.
Contribution of core components to Matero 
total  costs $32,347
ProTEST 
coordination
$1,446
4%
VCT
$8,532
26%
Preventive Therapy
$1,300
4%
YFS Outreach
$5,078
16%
ProTEST clinic
$15,991
50%
Contribution of core components to Chawama 
total costs $84,213
ProTEST 
coordination
$4,225
5%
VCT
$47,598
56% Preventive 
Therapy
$1,373
2%
YFS Outreach
$9,884
12%
ProTEST clinic
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down is given where supplies were less than 10% of total
economic costs.
Outcomes
Client flows through the various ProTEST components are
presented in Table 5. The number of people reached by
ProTEST was 3,604 in Chawama and 258 in Matero (7%
of the mature site) during the year of the costing. Coordi-
nation meetings were attended on average by 35 people in
Chawama and 21 people in Matero. Almost half the peo-
ple pre-test counselled were tested in Chawama, whereas
all people were tested in Matero. Around 90% (88%–
93%) of people tested completed the VCT process in both
sites. There was a large disparity between the HIV preva-
lence rates among VCT clients in the sites, 64% in Matero
and 29% in Chawama. Compliance with preventive ther-
apy in Matero (47%) was twice as high as compliance in
Chawama (23%). There were an estimated 1,020 visits to
ProTEST clinic in Chawama and 638 visits in Matero. Hos-
pice had 288 admissions. HBC cared for 400 and 153
patients in Chawama and Matero, respectively.
Average costs
The annual cost of ProTEST co-ordination was $1 and $5
per person reached in Chawama and Matero, respectively
(Table 5). The VCT cost per person pre-test counselled was
$13 in Chawama and $33 in Matero. Due to the high attri-
tion rate between pre-test counselling and testing, the cost
per person tested and cost per person completing the VCT
process did not vary as much between the sites. The cost
per person completing IPT ($29) was over four times the
cost per person starting IPT ($7) in Chawama. In Matero
it was about double, $38 and $18, respectively. The cost
per clinic visit was $10 in Chawama and $25 in Matero.
The estimated number of visits per patient was 2.6 and 4.1
in Chawama and Matero, respectively. This leads the
annual cost per client in Matero ($104) to be about dou-
ble that in Chawama ($53).
Sensitivity analysis
The impact of a number of assumptions made were
explored for their impact on unit costs (Tables 6 and 7).
The choice of allocation factor for ZAMBART office costs
had the greatest impact on component costs. When allo-
cated equally across components and sites, total Matero
Table 1: Total annual cost by component and cost category – Core components in Chawama
CORE COMPONENTS Chawama
Cost Category Coordination VCT IPT YFS outreach Clinic
ECONOMIC COSTS
$$ $ $$
Capital
Buildings 0 2147 0 1038 201
Equipment 0 467 0 40 23
Vehicles 44 0 0 0 271
Opening ceremony 349 0 0 0 0
Start-up 0 0 224 0 0
Training 0 639 0 0 0
Total capital costs 394 3252 224 1078 495
Recurrent
Personnel 1791 19169 341 4991 5658
Supplies 276 12835 100 357 5248
Vehicle operating & maintenance 13 2722 0 0 56
Building operating & maintenance 0 1405 0 0 0
Training/workshops 0 292 0 0 86
Outreach 0 1666 0 0 0
Indirect costs 1752 6151 619 3455 9574
Other 0 105 88 3 14
Total recurrent costs 3832 44346 1149 8806 20637
Component total (economic) 4,225 47,598 1,373 9,884 21,132
Site total (economic) 84,213
FINANCIAL COSTS
Component total (financial) 3,600 31,765 1,273 7,100 19,676
Cost represented in 2007 US$
Abbreviations: VCT: voluntary counselling and testing; IPT: isoniazid preventive therapy; YFS: youth friendly services.Cost Effectiveness and Resource Allocation 2008, 6:2 http://www.resource-allocation.com/content/6/1/2
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costs increased. In both sites unit costs for IPT increased
by about 3-fold, while ProTEST clinic unit costs dropped
by 30% and 25% in Chawama and Matero, respectively.
Variations in discount rate, and a faster IPT drop-out rate
had a small impact on unit costs, less than 10% variation
in unit costs. Had full VCT compliance been assumed,
rather than actually measured, we would have dramati-
cally underestimated the cost per person tested, and per
person completing the full VCT process. Although the
costs were fairly robust to assumptions made in this anal-
ysis, they were quite sensitive to the allocation factors
used for the indirect costs from ZAMBART, and the
number of clinic visits. We also modelled the impact of
the ProTEST Initiative without an international director
(Table 8). This would reduce the costs of coordination by
about a quarter.
Discussion
This study looked at the costs of providing a package of
care to PLWH as implemented in the Zambian ProTEST
Initiative. It not only looks at service components (VCT,
IPT, clinic, outreach, and hospice and HBC) but also
measures the cost of co-ordinating these services to pro-
vide a core package of care for PLWH. Annual costs of the
core package of services ranged from $32,347 in the
smaller site to $84,213 in the larger site. The introduction
of ProTEST has led to enhanced collaboration and
improved referral systems for as little as $1 per person
reached.
There were a number of striking differences between the
two sites. The Matero site operated on a much smaller
scale than the Chawama site. The client numbers were
mostly constrained on the supply-side. Group counselling
in Chawama made it possible to reach many people with
pre-test counselling. The Matero VCT service had no space
for group counselling, there was only a single counsellor,
and the health centre (including the VCT service) was
closed for a couple of months. On the demand side, it
takes time for people to hear about the service and start
coming. When people do start presenting, new VCTs tend
to attract the people with more advanced symptoms of
AIDS [49,50].
Table 2: Total annual cost by component and cost category – Core components in Matero
CORE COMPONENTS Matero
Cost Category Coordination VCT IPT YFS outreach Clinic
ECONOMIC COSTS
$$ $$ $
Capital
Buildings 0 399 0 340 455
Equipment 0 212 0 243 27
Vehicles 12 0 0 0 228
Opening ceremony 86 0 0 0 0
Start-up 899 0 168 0 0
Training 0 0 0 0 0
Total capital costs 97 611 168 583 710
(including start-up) 996 0 0 0 0
Recurrent
Personnel 547 2627 451 2719 5064
Supplies 162 3368 47 202 3081
Vehicle operating & maintenance 3 424 0 0 47
Building operating & maintenance 0 219 0 0 0
Training/workshops 0 46 0 0 0
Outreach 0 260 0 0 0
Indirect costs 636 959 589 1574 7089
Other 0 18 44 0 0
Total recurrent costs 1349 7921 1132 4495 15281
Component total (economic) 1,446 8,532 1,300 5,078 15,991
(including start-up) 2540
Site total (economic) 32,347
FINANCIAL COSTS
Component total (financial) 1,308 3,878 1,211 2,353 14,568
Cost represented in 2007 US$
Abbreviations: VCT: voluntary counselling and testing; IPT: isoniazid preventive therapy; YFS: youth friendly services.Cost Effectiveness and Resource Allocation 2008, 6:2 http://www.resource-allocation.com/content/6/1/2
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Table 3: Total annual cost by component and cost category – affiliated services
AFFILIATED SERVICES
Chawama Matero Both sites
Cost Category HBC HBC Hospice
ECONOMIC COSTS
$$$
Capital
Buildings 733 279 56126
Equipment 364 139 3801
Vehicles 545 208 5859
Opening ceremony 0 0 0
Start-up 0 0 0
Training 2010 766 1964
Total capital costs 3652 1392 67749
Recurrent
Personnel 9495 3620 40895
Supplies 45055 17177 23437
Vehicle operating & maintenance 1049 400 6382
Building operating & maintenance 265 101 2191
Training/workshops 25 9 1123
Outreach 0 0 0
Indirect costs 0 0 12542
Other 0 0 4774
Total recurrent costs 55890 21308 91343
Component total (economic) 59,541 22,700 159,093
FINANCIAL COSTS
Component total (financial) 13,483 5,140 60,739
Cost represented in 2007 US$
Abbreviations: HBC: home based care.
Table 4: Major inputs contributors (>10%) in the largest economic cost categories (Personnel and Supplies)
Personnel Inputs % of personnel economic costs Supplies Inputs % of supplies economic costs
Chawama Matero Chawama Matero
Coordination Director 35% 45% <10% of total economic costs
Project coordinator 32% 27%
Meeting attendees 21% 10%
VCT Counsellors 64% 94% Test kits 43% 44%
Mobilisers 18% N.A. Information pamphlets 24% 14%
Office supplies 7% 27%
IPT Counsellors 45% 63% Isoniazid tablets 13% 7%
YFS outreach YFS volunteers 58% 80% <10% of total economic costs
Clinic Medical doctor (director) 13% 17% Drugs & medical supplies 99% 98%
Medical doctor (project coordinator) 61% 58%
Medical officer 16% 16%
Driver 10% 9%
Both sites Both sites
HBC Core staff 16% Food 89%
Urban volunteer 70%
Hospice Care givers (paid, volunteer) (19%, 9%) Drugs & medical supplies 49%
Nurses 10% Community donations (mostly food) 36%
VCT: voluntary counselling and testing; IPT: isoniazid preventive therapy; YFS: youth friendly services; HBC: home based care.Cost Effectiveness and Resource Allocation 2008, 6:2 http://www.resource-allocation.com/content/6/1/2
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Table 5: Outputs and unit costs
Chawama Matero
Outputs Unit cost Outputs Unit cost
Core components
ProTEST coordination
person reached 3,604 $1 258 $6
(including start-up) ($9)
VCT
people pre-test counselled 3,604 $13 258 $33
people tested 1,575 $30 258 $33
people receiving results 1,381 $34 239 $36
HIV+ cases found 455 $105 166 $51
IPT
people starting 204 $7 73 $18
people completing 47 $29 35 $38
ProTEST clinic
clinic visits 2115 $10 638 $25
clients eligible for clinic* 399 $53 154 $104
Affiliated services
HBC**
clients 400 $149 153 $149
Hospice***
admissions 288 $552
bednights 6685 $24
Cost represented in 2007 US$
Abbreviations: VCT: voluntary counselling and testing; IPT: isoniazid preventive therapy; HBC: home based care.
* Estimated number of clients attending clinic, based on those eligible: HIV+ and collected results.
** Costing for Jan-Dec 2000
*** hospice was in one location only, but receive patients from the surrounding areas, including Matero and Chawama
Table 6: Sensitivity analysis: The impact of discount rate on unit costs (in percentage change)
Baseline Unit costs Discount rate 3% Discount rate 0% Discount rate 6%
Cost per Chawama Matero Chawama Matero Chawama Matero
ProTEST coordination
person reached $1.10 $5.26 -1% -1% 1% 1%
VCT
people pre-test counselled $12.40 $31.05 -0.2% -0.3% 0.2% 0.3%
people tested $28.38 $31.05 -0.2% -0.3% 0.2% 0.3%
people receiving results $32.36 $33.52 -0.2% -0.2% 0.2% 0.3%
HIV+ cases found $98.22 $48.26 -0.2% -0.2% 0.2% 0.2%
IPT
people starting $6.32 $16.71 0% 0% 0% 0%
people completing $27.48 $35.29 0% 0% 0% 0%
ProTEST clinic
clinic visits $9.38 $23.53 -0.3% -0.3% 0.3% 0.3%
clients eligible for clinic $49.73 $97.64 -0.3% -0.3% 0.3% 0.3%
HBC
clients $139.77 $139.77 -0.2% -0.2% 0.2% 0.2%
Hospice
admissions $518.68 -0.4% 0.4%
bednights $22.35 -0.4% 0.4%
Cost represented in 2007 US$
Abbreviations: VCT: voluntary counselling and testing; IPT: isoniazid preventive therapy; YFS: youth friendly services; HBC: home based care.Cost Effectiveness and Resource Allocation 2008, 6:2 http://www.resource-allocation.com/content/6/1/2
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Table 8: The impact of no international staff on unit costs (in percentage change)
Baseline Unit costs No international staff**
Cost per Chawama Matero Chawama Matero
ProTEST coordination
person reached $1.10 $5.26 -23% -26%
VCT
people pre-test counselled $12.40 $31.05 no change to baseline
people tested $28.38 $31.05 no change to baseline
people receiving results $32.36 $33.52 no change to baseline
HIV+ cases found $98.22 $48.26 no change to baseline
IPT
people starting $6.32 $16.71 -5% -5%
people completing $27.48 $35.29 -5% -5%
ProTEST clinic
clinic visits $9.38 $23.53 -9% -11%
clients eligible for clinic $49.73 $97.64 -9% -11%
HBC
clients $139.77 $139.77 no change to baseline
Hospice
admissions $518.68 -1%
bednights $22.35 -1%
** The salary of the international director was replaced with that of the project coordinator.
Cost represented in 2007 US$
Abbreviations: VCT: voluntary counselling and testing; IPT: isoniazid preventive therapy; YFS: youth friendly services; HBC: home based care.
Table 7: Sensitivity analysis: The impact of equal allocation of joint ZAMBART costs and divers assumptions on unit costs (in 
percentage change)
Baseline Unit costs Equal allocation of joint ZAMBART costs* Diverse assumptions
Cost per Chawama Matero Chawama Matero Chawama Matero
ProTEST coordination
person reached $1.10 $5.26 34% 175%
VCT Full VCT compliance
people pre-test counselled $12.40 $31.05 no change to baseline 16% 151%
people tested $28.38 $31.05 no change to baseline -49% 10%
people receiving results $32.36 $33.52 no change to baseline -56% -4%
HIV+ cases found $98.22 $48.26 no change to baseline -56% -54%
IPT PT fast drop off of loss to follow-up
people starting $6.32 $16.71 185% 198% -8% 160%
people completing $27.48 $35.29 185% 198% -8% 26%
Estimated number of visits
ProTEST clinic 25% ↑ 25% ↓ 25% ↑ 25% ↓
clinic visits $9.38 $23.53 -30% -25% -20% 33% 101% 235%
clients eligible for clinic $49.73 $97.64 -30% -25%
HBC
clients $139.77 $139.77 no change to baseline
Hospice no change to baseline
admissions $518.68 no change to baseline
bednights $22.35
Cost represented in 2007 US$
Abbreviations: VCT: voluntary counselling and testing; IPT: isoniazid preventive therapy; YFS: youth friendly services; HBC: home based care.
* to the service provided by ZAMBART: coordination, IPT, YFS, ProTEST clinicCost Effectiveness and Resource Allocation 2008, 6:2 http://www.resource-allocation.com/content/6/1/2
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The HIV prevalence in Matero was very high (64%), while
the HIV prevalence among VCT clients in Chawama
(29%) was more representative of the prevalence in the
general population (22%). This difference can also be rec-
ognised in the behaviour of clients. While in Matero a very
high proportion of clients completed the full process
(92%), the Chawama VCT experienced high rates of peo-
ple not proceeding to testing after pre-test counselling.
The high drop-out rate may have a few reasons. Group
counselling made it possible to pre-test counsel large
groups. Many group counselling sessions were for school
children who needed parental permission to test. These
youths were educated about HIV at Chawama, but unable
to test. Additionally, mobilisers received a bonus for each
person presenting for pre-test counselling with their refer-
ral slips. The number of ProTEST clinic visits per client in
Matero was 62% higher than Chawama again suggesting
a more advanced stage of HIV in the clients in Matero.
Limitations
A number of caveats must be considered in this analysis.
The allocation of indirect costs had a large influence on
component costs, although not on costs of ProTEST as a
whole. As start-up costs were not collected for Chawama,
both site costs are presented excluding start-up costs. A
number of variables were estimated retrospectively, such
as staff time allocations. The line item of HIV test kits for
VCT was modelled as KCTT had complemented their pur-
chased test kits with donated kits of unknown number.
Quantities were estimated by the number of HIV test per-
formed plus an estimated 10% wastage. International
prices for these kits were then applied. The HBC costs are
the average costs over all sites, and are therefore not site
specific. Cost-effectiveness in terms of HIV infections
averted would need to be estimated in order to compare
ProTEST with other HIV interventions. This requires
behavioural surveys and modelling or a randomised inter-
vention design. Although the direct costs of research were
removed, time input by international staff into the daily
running and co-ordination of the intervention were
included at full costs. Therefore if replicating ProTEST out-
side of the pilot intervention setting cost, personnel cost
particularly, are expected about a quarter lower (Table 8).
A more general limitation of this study is that it was con-
ducted before the widespread availability of ART. The
integration of services is however as relevant in the ART
era as at the time of this study, but costs due to the provi-
sion of ART would need to be factored in.
Comparison with other studies
The cost of VCT was around $35 per client receiving
results, which is consistent with other studies of the cost
of VCT in Africa. Sweat et al. estimated the cost of VCT in
Kenya and Tanzania and found a cost per VCT client of
$34 and $37 (adjusted to 2007 dollars) [29]. A key differ-
ence from our study is that Sweat et al. assumed all clients
presenting for pre-test counselling return for their test
results, whereas we were able to measure this and estimate
average costs for multiple VCT outputs, incorporating
attrition rates. Aisu et al. estimated the cost of VCT in
Uganda to be $30 [37]. Our cost per client tested did not
differ greatly from these estimates ($34 and $36). For-
sythe estimated the incremental financial cost of VCT inte-
grated into health centres at $19 per client [34]. It is not
clear what 'client' means in terms of completing the VCT
process. These differences make it difficult to compare
these results with our VCT costs. Despite low IPT adher-
ence, its implementation costs were relatively low: $29 to
$38 per person completing IPT. The modelled estimate of
the cost effectiveness of IPT by Shresta et al. in Uganda was
$58 [51]. We have not considered the additional benefits
of early detection of active TB or the medical cost averted
due to averting TB infections. Three studies modelled the
treatment cost savings attributable to IPT in Africa using
secondary data [30,33,36]. Bell estimated a savings in
terms of medical costs averted of $34 per person [36].
Masobe et al. performed a least cost analysis for a hypo-
thetical cohort of 100,000 HIV-positive patients over 8
years and estimated IPT could result in a net savings of
$19 million (or $193 per person) [30]. Foster et al.
included in benefits not only treatment costs, but also lost
wages averted and found a benefit cost ratio of 1.86 [33].
The larger number of annual clinic visits per patient to
ProTEST clinic in Matero (4.1) than in Chawama (2.6) is
consistent with the findings by Kinghorn et al. who found
the annual number of outpatient visits in South Africa
increased strongly from stage 1 HIV (3.8 visits annually)
to stage 4 HIV (6.29 visits annually) [52]. The cost per out-
patient hospital visit for PLWH in Thailand was $27 [53],
again very close to the cost per ProTEST clinic visit. The
daily cost of hospice care is shown to be within the range
of in-patient hospital cost for AIDS patients in low-
income African countries, ranging from $9 to $49.
Hansen et al. estimate the cost of HBC in Zimbabwe rang-
ing from $23 to $33 per visit in two urban areas, this came
to $34–$253 per patient per year, with a large difference
between the sites in the average number of visits per
patient [32].
Conclusion
In many locations a range of preventive and clinical serv-
ices for HIV exist. This study shows that it is feasible to
integrate these services to provide a package of care for
PLWH. Without such a continuum of care ART provision
makes no sense. VCT must be expanded to allow access to
ART. Some clients may not yet need ART but still need
screening for other diseases, such as TB, and provision of
preventive therapy. Patients accessing ART also needCost Effectiveness and Resource Allocation 2008, 6:2 http://www.resource-allocation.com/content/6/1/2
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screening for TB and may similarly still require preventive
therapies, although the additional benefit of preventive
therapy in this setting is currently unclear. The provision
of ART still requires a broader range of services for PLWH
including symptom-; symptom management, palliative
care and HBC will still be required by some patients.
Without integration of services and collaboration
between service providers, HIV care will not be successful.
List of abbreviations
ART Anti-retroviral therapy
HBC Home based care
IPT Isoniazid preventive therapy
PLWH People living with HIV
TB Tuberculosis
VCT Voluntary counselling and HIV testing
YFS Youth friendly services
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